Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: Framingham Heart Study
Year: 2015
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: We investigated the association between circulating biomarkers of inflammation and MRI markers of small vessel disease. METHODS: We performed a cross-sectional study relating a panel of 15 biomarkers, representing systemic inflammation (high-sensitivity C-reactive protein, interleukin-6, monocyte chemotactic protein-1, tumor necrosis factor α, tumor necrosis factor receptor 2, osteoprotegerin, and fibrinogen), vascular inflammation (intercellular adhesion molecule 1, CD40 ligand, P-selectin, lipoprotein-associated phospholipase A2 mass and activity, total homocysteine, and vascular endothelial growth factor), and oxidative stress (myeloperoxidase) to ischemic (white matter hyperintensities/silent cerebral infarcts) and hemorrhagic (cerebral microbleeds) markers of cerebral small vessel disease (CSVD) on MRI in 1,763 stroke-free Framingham offspring (mean age 60.2 ± 9.1 years, 53.7% women). RESULTS: We observed higher levels of circulating tumor necrosis factor receptor 2 and myeloperoxidase in the presence of cerebral microbleed (odds ratio [OR] 2.2, 95% confidence interval [CI] 1.1-4.1 and OR 1.5, 95% CI 1.1-2.0, respectively), higher levels of osteoprotegerin (OR 1.1, 95% CI 1.0-1.2), intercellular adhesion molecule 1 (OR 1.7, 95% CI 1.1-2.5), and lipoprotein-associated phospholipase A2 mass (OR 1.5, 95% CI 1.1-2.1), and lower myeloperoxidase (OR 0.8, 95% CI 0.7-1.0) in participants with greater white matter hyperintensity volumes and silent cerebral infarcts. CONCLUSIONS: Our study supports a possible role for inflammation in the pathogenesis of CSVD, but suggests that differing inflammatory pathways may underlie ischemic and hemorrhagic subtypes. If validated in other samples, these biomarkers may improve stroke risk prognostication and point to novel therapeutic targets to combat CSVD.
Source: Neurology
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: cerebral small vessel disease, cerebral microbleeds, white matter hyperintensities, silent cerebral infarction, inflammatory markers, vascular inflammation, oxidative stress, tumor necrosis factor receptor 2, myeloperoxidase, osteoprotegerin, ICAM-1, lipoprotein-associated phospholipase A2, C-reactive protein, interleukin-6, fibrinogen, stroke risk
Open Access status: hybrid
Awards: UC Davis Alzheimer's Disease Core Center, G250621538, Risk Factors, Genetics and Cognition in Cerebral Microbleeds: Framingham Study, Neurotrophic Factors: Genetic Variation and Serum Levels in Brain Aging, Aging and Inflammation: Longitudinal Markers and Genetics in the Framingham Study, INFLAMMATION: CORRELATES AND PROGNOSIS IN FRAMINGHAM, Cerebral Microbleeds in Young Adults: risk factors, biomarkers and genetics, Framingham: Inflammation, Genes & Cardiovascular Disease, MRI, Genetics & Cognitive Precursors of AD and Dementia, The Framingham Heart Study, AD Gene Discovery: Exome Chip, New Endophenotypes & Functional Studies in CHARGE, Epidemiology of Dementia in the Framingham Study, Precursors of Stroke Incidence and Prognosis
OpenAlex ID: W2107023383
